Rani Therapeutics Holdings, Inc. (RANI) has 6 SEC Form 4 insider filings on record in the last 90 days. That includes 2 insider purchases totalling $50K, and 2 sales totalling $56K. Most recent filing: Aug. 4, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 4, 2026 filed Aug. 3, 2026 | Gilson Michelle Director | $0 | 247,200 | 0% | No | |
|
|
||||||
| July 23, 2026 filed July 21, 2026 | IMRAN MIR A Director | +$24,840 | 36,000 | +2% | No | |
|
|
||||||
| July 21, 2026 filed March 27, 2026 | Javadi Alireza Chief Technical Officer | −$530 | 695 | −7% | No | |
|
|
||||||
| July 21, 2026 filed July 17, 2026 | Imran Talat Chief Executive Officer | +$25,193 | 35,000 | +8% | No | |
|
|
||||||
| July 21, 2026 filed Dec. 27, 2024 | Imran Talat Chief Executive Officer | −$55,028 | 60,015 | −12% | No | |
|
|
||||||
Showing the 5 most recent of 6 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free